Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$51.67K$51.67Kderived−68.7% vs Q4 2017 Net Income-$2.47M-$2.47MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,944,490N/M Operating Cash Flowderived-$439,417N/M Free Cash Flowderived-$419,654— Margins · derivedOperating margin-3763.0%−3139.4 pt vs Q4 2017
Net margin-4788.7%−3835.5 pt vs Q4 2017
ended Dec 31, 2018 · filed Apr 16, 2019 · 106 d after period end